2 Patents
- US120545572024Combination of Anti-pd-1 Antibodies and Bispecific Anti-cd20/anti-cd3 Antibodies to Treat Cancer
Regeneron Pharmaceuticals, Inc.
0 cites - US115902232023Dosing Strategy That Mitigates Cytokine Release Syndrome for Therapeutic Antibodies
Regeneron Pharmaceuticals, Inc.
0 cites